US Patent Issued to Baxter International, Baxter Healthcare on Sept. 1 for "Pharmaceutically acceptable ready-to-use ferric carboxymaltose compositions" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,859, issued on Sept. 1, was assigned to Baxter International Inc. (Deerfield, Ill.) and Baxter Healthcare SA (Glattpark, Switzerland).

"Pharmaceutically acceptable ready-to-use ferric carboxymaltose compositions" was invented by Mahesh V Chaubal (Kildeer, Ill.), Jason Robert Mantei (Volo, Ill.) and Kelly Ann Parker (Buffalo Grove, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical product includes a sealed container and further includes a pharmaceutically suitable ready-to-use ferric carboxymaltose premix composition in the sealed container. The ferric carboxymaltose premix composition contains water, sodium chloride, and ferric ca...